Affimed N.V. (NASDAQ: AFMD) is -6.45% lower on its value in year-to-date trading and has touched a low of $1.03 and a high of $5.10 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AFMD stock was last observed hovering at around $1.22 in the last trading session, with the day’s loss setting it -0.06% off its average median price target of $6.64 for the next 12 months. It is also 90.59% off the consensus price target high of $12.33 offered by 10 analysts, but current levels are 38.3% higher than the price target low of $1.88 for the same period.
Currently trading at $1.16, the stock is -0.81% and -27.78% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.36 million and changing -4.92% at the moment leaves the stock -54.18% off its SMA200. AFMD registered -71.98% loss for a year compared to 6-month loss of -60.81%.
The stock witnessed a 0.87% gain in the last 1 month and extending the period to 3 months gives it a -23.68%, and is 1.75% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 7.12% over the week and 7.26% over the month.
Affimed N.V. (AFMD) has around 187 employees, a market worth around $162.31M and $43.90M in sales. Distance from 52-week low is 12.62% and -77.25% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.40%).
Affimed N.V. (AFMD) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Affimed N.V. (AFMD) is a “Buy”. 10 analysts offering their recommendations for the stock have an average rating of 1.90, where 1 rate it as a Hold and 0 think it is a “Overweight”. 9 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Affimed N.V. is expected to release its quarterly report on 05/17/2023.The EPS is expected to grow by 2.90% this year.
Affimed N.V. (AFMD) Top Institutional Holders
The shares outstanding are 149.34M, and float is at 137.53M with Short Float at 2.91%.
Affimed N.V. (AFMD): Who are the competitors?
The company’s main competitors (and peers) include Acorda Therapeutics Inc. (ACOR) that is trading -48.46% down over the past 12 months.